Lucid Diagnostics Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-11.7M | $-13.9M | $-16.3M | $-10.4M | $-4.4M | $-26.9M | $-11.5M | $-12.4M |
| Depreciation & Amortization | $224.0K | $222.0K | $209.0K | $220.0K | $222.0K | $221.0K | $222.0K | $215.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $105.0K | $105.0K | $106.0K | $105.0K | $105.0K | $105.0K | $106.0K | $105.0K |
| Stock-Based Compensation | — | — | — | $1.1M | $1.1M | $949.0K | $1.1M | $1.2M |
| Net Cash from Operating Activities | $-11.3M | $-12.1M | $-12.6M | $-10.9M | $-10.5M | $-12.5M | $-9.9M | $-10.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $21.0K | $215.0K | — | — | $25.0K | $93.0K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-21.0K | $-215.0K | $-51.0K | $-28.0K | $-25.0K | $-93.0K | $-259.0K | $-350.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $16.8M | $5.5M | $2.0K | $27.1M | $16.5M | $15.4M | $18.0M | $94.0K |
| Net Change in Cash | $5.5M | $-6.8M | $-12.6M | $16.2M | $5.9M | $2.9M | $7.9M | $-10.4M |
| Free Cash Flow | $-11.3M | $-12.3M | — | — | $-10.6M | $-12.6M | — | — |